- Home
- About Us
- Industry
- Services
- Reading
- Contact Us
Emphasis on Product (Abdominal Aortic Stent Grafts and Thoracic Aortic Stent Grafts); End-user (Hospitals, Ambulatory Surgical Centers, and Others); and Region/Country
The Global Aortic Stent Grafts Market was valued at USD 3,598.12 million in 2024 and is expected to grow to a strong CAGR of around 6.8% during the forecast period (2025-2033F), driven by rising prevalence of aortic aneurysms, increasing demand for minimally invasive procedures, and technological advancements in graft design.
Aortic stent graft is a kind of medical device, applied in the treatment of aortic aneurysms and dissections in the areas of the thoracic and abdominal aorta. They are made up of a stent, which is a metal mesh, to reinforce the weakened aorta and combine it with a fabric graft that prevents rupture. Growth of the global aortic stent grafts market is broad-based and driven by a series of key factors. With a growing number of people suffering from aortic aneurysms, especially in the elderly and individuals with lifestyle-related risk factors such as hypertension and smoking, there has been a heavy demand for efficient treatments.
This section discusses the key market trends that are influencing the various segments of the global aortic stent grafts market, as found by our team of research experts.
Growth in Thoracic Aortic Stent Grafts (TEVAR)
The thoracic aortic stent graft segment is expected to grow at a robust rate due to the high prevalence of thoracic aortic aneurysms and technological advancements in the endovascular repair procedures. With less invasion than open surgery, TEVAR provides for a shorter recovery time, fewer complications, and a shorter hospital stay. Encouraging the use of TEVAR in broader patient populations is the increasing clinical evidence supporting its long-term efficacy in addition to expanding indications. TEVAR is expected to show strong growth in the coming years as it is enabled with ongoing R&D and training of vascular specialists.
This section provides an analysis of the key trends in each segment of the global aortic stent grafts market report, along with forecasts at the global, regional, and country levels for 2025-2033.
The Abdominal Aortic Stent Grafts Market dominates the Global Aortic Stent Grafts market
Based on the product category, the market is categorized into abdominal aortic stent grafts and thoracic aortic stent grafts. Out of these, the abdominal aortic stent grafts market currently holds the largest market share because of the prevalence of abdominal aortic aneurysms (AAAs), which is higher in the elderly and individuals prone to high risk. The adoption of these devices is widespread because of well-established EVAR procedures, broad clinical experience, and favorable reimbursement policies. Moreover, frequent product launches by leading players are further propelling the market.
For instance, in August 2024, Terumo India, the Indian subsidiary of Terumo Corporation, which is a global leader in medical technology, announced the launch of the TREO® Stent-Graft System, which is an advanced solution for Endovascular Aneurysm Repair (EVAR). Designed specifically for the treatment of infrarenal abdominal aortic aneurysms in adults with suitable anatomies, the TREO® Stent-Graft System stands out as the only EVAR graft featuring both suprarenal and infrarenal active fixation. These innovative product launches are accelerating the growth of the aortic stent grafts market worldwide.
The Hospitals segment dominates the Global Aortic Stent Grafts market.
Based on the end-user category, the market is categorized into hospitals, ambulatory surgical centers, and others. Among these, hospitals hold the largest market share. Their advanced medical infrastructure, including specialized vascular surgery units and the ability to tackle complex procedures like EVAR and TEVAR, makes them dominant. Besides, hospitals are the first choice for such interventions because they offer multidisciplinary teams that can perform the procedures efficiently. However, ambulatory surgical centers (ASCs) are expected to grow rapidly in the future. Changing dynamics towards minimally invasive procedures have created additional benefits, including lower cost, shorter recovery time, and lower infection risk, and the aforementioned two factors have made ASCs an increasingly preferred alternative to patients and healthcare providers.
The North America region dominates the Global Aortic Stent Grafts Market.
The aortic stent grafts market in North America has the largest share, and this can be attributed to the high adoption of advanced medical technologies, the strong presence of key players in the region, as well as the region’s well-established healthcare infrastructure. High occurrence of aortic aneurysms in the region, especially within the aging population, has resulted in high demand for an effective treatment solution. Additionally, good reimbursement policies and extensive use of minimally invasive procedures such as EVAR and TEVAR boosted procedure volumes. The sustained investment in R&D and the early adoption of innovative stent graft technology also reinforce its dominant position in this market, hence making North America the leading region in this sector.
The United States held a Dominant share of the North America Aortic Stent Grafts Market in 2024
Various key factors have put the United States in a dominant position in the North American market for aortic stent grafts. The country is attributed to this dominance owing to its advanced healthcare infrastructure, higher prevalence of aortic aneurysm, and its early adoption of innovative medical technologies. On the other hand, the favorable reimbursement policies of the U.S. and the presence of big players like Medtronic and W.L. Gore & Associates further support ongoing research and product development of the concerned industry. Moreover, the growth of the geriatric population and enhanced awareness about minimally invasive procedures, i.e., EVAR and TEVAR, are fostering the growth of the market.
The global aortic stent grafts market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions.
Some of the major players in the market are Terumo Corporation, Medtronic, Meril Life Science, Cook Group Incorporated, Braile Biomédica, Artivion, Inc., W. L. Gore & Associates, Inc., Endologix LLC, MicroPort Scientific, and Bentley InnoMed GmbH.
Recent Developments in the Aortic Stent Grafts Market
In April 2025– Zydus MedTech, a wholly owned subsidiary of Zydus Lifesciences, announced its strategic partnership with Braile Biomedica, which is a cardiovascular device manufacturer based in Brazil, to exclusively commercialize its Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and other select markets.
In December 2023– TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, announced the completion of its latest acquisition of Seisa Medical in a deal that significantly extends TekniPlex Healthcare’s medical technology solutions platform. This acquisition specifically enhances the company’s materials science and process technologies for minimally invasive and interventional therapy devices on a global scale, including products such as aortic stent grafts.
Report Attribute | Details |
Base year | 2024 |
Forecast period | 2025-2033 |
Growth momentum | Accelerate at a CAGR of 6.8% |
Market size 2024 | USD 3,598.12 Million |
Regional analysis | North America, Europe, APAC, Rest of the World |
Major contributing region | Asia-Pacific is expected to dominate the market during the forecast period. |
Key countries covered | U.S., Canada, Germany, U.K., Spain, Italy, France, China, Japan, and India |
Companies profiled | Terumo Corporation, Medtronic, Meril Life Science, Cook Group Incorporated, Braile Biomédica, Artivion, Inc., W. L. Gore & Associates, Inc., Endologix LLC, MicroPort Scientific, and Bentley InnoMed GmbH. |
Report Scope | Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Demand and Supply Side Analysis; Competitive Landscape; Company Profiling |
Segments Covered | By Product, By End-User, By Region/Country |
The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.
The report briefly reviews overall industry performance at a glance.
The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.
Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
The study comprehensively covers the market across different segments.
Deep dive regional level analysis of the industry.
The global Aortic Stent Grafts market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.
We analyzed the historical market, estimated the current market, and forecasted the future market of the global aortic stent grafts market to assess its application in major regions worldwide. We conducted exhaustive secondary research to gather historical market data and estimate the current market size. To validate these insights, we carefully reviewed numerous findings and assumptions. Additionally, we conducted in-depth primary interviews with industry experts across the aortic stent grafts value chain. After validating market figures through these interviews, we used both top-down and bottom-up approaches to forecast the overall market size. We then employed market breakdown and data triangulation methods to estimate and analyze the market size of industry segments and sub-segments.
We employed the data triangulation technique to finalize the overall market estimation and derive precise statistical numbers for each segment and sub-segment of the global aortic stent grafts market. We split the data into several segments and sub-segments by analyzing various parameters and trends, including product, end-user, and regions within the global aortic stent grafts market.
The study identifies current and future trends in the global aortic stent grafts market, providing strategic insights for investors. It highlights regional market attractiveness, enabling industry participants to tap into untapped markets and gain a first-mover advantage. Other quantitative goals of the studies include:
Market Size Analysis: Assess the current and forecast market size of the global aortic stent grafts market and its segments in terms of value (USD).
Aortic Stent Grafts Market Segmentation: Segments in the study include areas of product, end-user, and region.
Regulatory Framework & Value Chain Analysis: Examine the regulatory framework, value chain, customer behavior, and competitive landscape of the aortic stent grafts industry.
Regional Analysis: Conduct a detailed regional analysis for key areas such as Asia Pacific, Europe, North America, and the Rest of the World.
Company Profiles & Growth Strategies: Company profiles of the aortic stent grafts market and the growth strategies adopted by the market players to sustain the fast-growing market.
Q1: What is the global aortic stent grafts market’s current market size and growth potential?
As of 2024, the global aortic stent grafts market is valued at approximately USD 3,598.12 million. It is projected to grow at a robust CAGR of 6.8% from 2025 to 2033, driven by rising demand for minimally invasive vascular procedures and a growing elderly population.
Q2: Which segment has the largest share of the global aortic stent grafts market by product category?
The abdominal aortic stent graft segment currently holds the largest market share. This dominance is due to the high prevalence of abdominal aortic aneurysms (AAA) and the widespread adoption of endovascular aneurysm repair (EVAR) procedures.
Q3: What are the driving factors for the growth of the global aortic stent grafts market?
Key drivers fueling market growth include the increasing incidence of aortic aneurysms, the rising adoption of minimally invasive techniques like EVAR and TEVAR, and continuous advancements in stent graft technology, improving procedural outcomes.
Q4: What are the emerging technologies and trends in the global aortic stent grafts market?
Major trends shaping the market include the rapid expansion of thoracic aortic stent grafts (TEVAR), growing use of fenestrated and branched stent grafts for complex cases, and the integration of data-driven post-market surveillance to enhance device safety and performance.
Q5: What are the key challenges in the global aortic stent grafts market?
The industry faces challenges such as the high cost of aortic stent graft procedures, limited access in low-income regions, and stringent regulatory hurdles that slow the approval and commercialization of new technologies.
Q6: Which region dominates the global aortic stent grafts market?
North America currently dominates the global aortic stent grafts market, primarily due to its advanced healthcare infrastructure, strong reimbursement systems, high prevalence of aortic disorders, and the presence of leading medical device companies.
Q7: Who are the key companies in the global aortic stent grafts market?
Top players in the aortic stent grafts industry include:
• Terumo Corporation
• Medtronic
• Meril Life Science
• Cook Group Incorporated
• Braile Biomédica
• Artivion, Inc.
• W. L. Gore & Associates, Inc.
• Endologix LLC
• MicroPort Scientific
• Bentley InnoMed GmbH
Q8: What are the key investment opportunities in the global aortic stent grafts market?
Key investment opportunities lie in the development of next-generation fenestrated and branched stent grafts, expansion into emerging markets with rising healthcare spending, and digital integration in post-operative monitoring. Players investing in AI-driven imaging solutions, customizable graft designs, and value-based care models are expected to gain a competitive edge.
Q9: How are regulatory changes and compliance standards shaping product development in the aortic stent grafts market?
Regulatory changes, such as stricter FDA guidelines and EU MDR regulations, are significantly influencing product development timelines and approval strategies. Manufacturers must now emphasize real-world evidence, post-market surveillance, and risk-benefit analyses to ensure compliance, making regulatory agility and quality assurance critical for market success.
Customers who bought this item also bought